Cellcura ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cellcura ASA Extends Subscription Period for Private Placement
Cellcura ASA announced that with reference to the announcement of November 13, 2012 in respect of the approved prospectus for listing of shares and commencement of the subscription period in the Company's private placement and subsequent offering, Cellcura ASA has resolved to extend the subscription period up to December 12, 2012 at 16:00 Central European Time (CET). It is expected that payment for subscribed shares will be made on December 17, 2012. Trading in issued shares is expected to commence on or about December 20, 2012. The shares will be delivered through the facilities of the VPS. The extension is made in order to provide remaining potential subscribers an opportunity to finalize their internal investment decisions.
Latest Developments for Cellcura ASA
Latest Key Developments in Medical
- Getinge AB issues Q1 2014 profit outlook below analysts' estimates
- Tandem Diabetes Care Inc gives FY 2014 revenue guidance in line with analysts' estimates
- DiaSorin SpA announces 0.55 euros per share dividend for FY 2013; issues FY 2014 revenues and EBITDA guidance
- Newmax Technology Co Ltd announces FY 2013 dividend payment
- Share this
- Digg this